129 related articles for article (PubMed ID: 4049537)
21. [Assessment of regional and systemic toxicity of isolated hyperthermic extremity perfusion with tumor necrosis factor-alpha and melphalan].
Hohenberger P; Haier J; Kettelhack C; Schulze G; Schlag PM
Chirurg; 1997 Sep; 68(9):914-20. PubMed ID: 9410682
[TBL] [Abstract][Full Text] [Related]
22. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
[TBL] [Abstract][Full Text] [Related]
23. Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?
Olieman AF; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Arch Orthop Trauma Surg; 1998; 118(1-2):70-4. PubMed ID: 9833110
[TBL] [Abstract][Full Text] [Related]
24. FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
van Ginkel RJ; Hoekstra HJ; Pruim J; Nieweg OE; Molenaar WM; Paans AM; Willemsen AT; Vaalburg W; Koops HS
J Nucl Med; 1996 Jun; 37(6):984-90. PubMed ID: 8683328
[TBL] [Abstract][Full Text] [Related]
25. [On the method of hyperthermic chemotherapy by regional isolated perfusion for tumors of lower extremities].
Xu SW; Chen F; Chao YH
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):310-3. PubMed ID: 7805565
[TBL] [Abstract][Full Text] [Related]
26. Thermochemotherapy for soft tissue sarcoma.
Di Filippo F; Buttini GL; Calabro AM; Carlini S; Gianarelli D; Moscarelli F; Graziano F; Cavallari A; Cavaliere F; Cavaliere R
Cancer Treat Res; 1989; 44():111-27. PubMed ID: 2577158
[No Abstract] [Full Text] [Related]
27. Hyperthermic isolated limb perfusion in the management of extremity sarcoma.
Hoekstra HJ; van Ginkel RJ
Curr Opin Oncol; 2003 Jul; 15(4):300-3. PubMed ID: 12874508
[TBL] [Abstract][Full Text] [Related]
28. [Isolated limb hyperthermic perfusion chemotherapy for melanoma of the extremities].
Li J; Wang P; Zhu XJ; Song JG; Song JM
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):937-9. PubMed ID: 23336382
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in advanced soft-tissue sarcomas: histopathological considerations.
Issakov J; Merimsky O; Gutman M; Kollender Y; Lev-Chelouche D; Abu-Abid S; Lifschitz-Mercer B; Inbar M; Klausner JM; Meller I
Ann Surg Oncol; 2000 Mar; 7(2):155-9. PubMed ID: 10761796
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
[TBL] [Abstract][Full Text] [Related]
31. Soft tissue limb sarcomas: Italian clinical trials with hyperthermic antiblastic perfusion.
Rossi CR; Foletto M; Di Filippo F; Vaglini M; Anza' M; Azzarelli A; Pilati P; Mocellin S; Lise M
Cancer; 1999 Nov; 86(9):1742-9. PubMed ID: 10547547
[TBL] [Abstract][Full Text] [Related]
32. [Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase].
Di Filippo F; Garinei R; Anzà M; Cavaliere F; Botti C; Perri P; Di Filippo S
Tumori; 2003; 89(4 Suppl):241-3. PubMed ID: 12903606
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: ten years of successful antivascular therapy.
Eggermont AM; ten Hagen TL
Curr Oncol Rep; 2003 Mar; 5(2):79-80. PubMed ID: 12583823
[No Abstract] [Full Text] [Related]
34. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermic antiblastic perfusion with DTIC in stage IIIA-IIIAB melanoma of the extremities.
Vaglini M; Belli F; Marolda R; Prada A; Santinami M; Cascinelli N
Eur J Surg Oncol; 1987 Apr; 13(2):127-9. PubMed ID: 3556593
[TBL] [Abstract][Full Text] [Related]
36. Thermal induction and temperature control in the hyperthermic antiblastic regional perfusion with extra corporeal circulation.
Pace M; Filomena A; Galli A
Adv Exp Med Biol; 1990; 267():399-403. PubMed ID: 2088059
[TBL] [Abstract][Full Text] [Related]
37. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
38. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
Alegre JF; Duarte M; Sureda González M; Bretcha Boix P; Dussan C; Ballester A; Crespo A; Brugarolas Masllorens A
Cir Esp; 2012 Feb; 90(2):114-20. PubMed ID: 22225611
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities.
Pommier RF; Moseley HS; Cohen J; Huang CS; Townsend R; Fletcher WS
Am J Surg; 1988 May; 155(5):667-71. PubMed ID: 3369621
[TBL] [Abstract][Full Text] [Related]
40. Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremities.
Santinami M; Belli F; Cascinelli N; Rovini D; Vaglini M
J Surg Oncol; 1989 Nov; 42(3):201-8. PubMed ID: 2811386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
